Search

everythinglearnresearchcommunity

for

Search:↓

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Some congenital hair disorders improve with age and can be managed with treatments like minoxidil, retinoids, supplements, and gentle hair care, but there's no cure.

Rosacea severely affects the quality of life for many patients in China, especially young adults and those with appearance-related jobs.

Patients with chronic skin disorders often experience depression, anxiety, and reduced quality of life and may benefit from psychiatric help.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Alopecia patients in Hebei, China, have poor knowledge and negative attitudes but take proactive steps to manage the condition.

Improving education, insurance, and support can help scarring alopecia patients access better care.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

Proper planning for hair transplants is crucial for natural results, with careful patient selection and strategic graft placement being key factors.

Most patients were satisfied with diode laser hair removal and experienced no long-term side effects.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

Diabetic patients need tailored cosmetic treatments for skin aging, with new therapies showing promise.

Chemotherapy and certain hair care practices can cause severe hair matting.

Rosacea patients often discuss treatments and emotional struggles online, highlighting the need for professional support.

Estrogen therapy can help stabilize the hairline in transfeminine individuals.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Higher doses of isotretinoin may lead to more hair loss.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Alopecia areata patients need better education to improve their disease management.

Semaglutide may cause hair loss, but more research is needed to confirm this.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

A leukemia patient showed skin peeling similar to kwashiorkor, a severe protein deficiency.

A new gene mutation causes complete androgen insensitivity in a 16-year-old with a female appearance.

Diagnosing PCOS is challenging due to its complex and varied symptoms.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

TH07 treatment is promising for hair growth, with higher satisfaction in males.